Literature DB >> 21818732

Impact of smoking during pregnancy on functional coagulation testing.

Donna Dizon-Townson1, Connie Miller, Valerija Momirova, Baha Sibai, Catherine Y Spong, George Wendel, Katharine Wenstrom, Philip Samuels, Steve Caritis, Yoram Sorokin, Menachem Miodovnik, Mary J O'Sullivan, Deborah Conway, Ronald J Wapner, Steven G Gabbe.   

Abstract

Compounds that are systemically absorbed during the course of cigarette smoking, and their metabolites, affect the coagulation system and cause endothelial dysfunction, dyslipidemia, and platelet activation leading to a prothrombotic state. In addition, smoking increases the activity of fibrinogen, homocysteine, and C-reactive protein. We hypothesize that smoking may affect functional coagulation testing during pregnancy. A secondary analysis of 371 women pregnant with a singleton pregnancy and enrolled in a multicenter, prospective observational study of complications of factor V Leiden mutation subsequently underwent functional coagulation testing for antithrombin III, protein C antigen and activity, and protein S antigen and activity. Smoking was assessed by self-report at time of enrollment (<14 weeks). None of the functional coagulation testing results was altered by maternal smoking during pregnancy. Smoking does not affect the aforementioned functional coagulation testing results during pregnancy.
Copyright © 2012 by Thieme Medical Publishers, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21818732      PMCID: PMC3770153          DOI: 10.1055/s-0031-1285097

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  24 in total

1.  1994-1996 U.S. singleton birth weight percentiles for gestational age by race, Hispanic origin, and gender.

Authors:  G R Alexander; M D Kogan; J H Himes
Journal:  Matern Child Health J       Date:  1999-12

2.  Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.

Authors:  D Tormene; P Simioni; P Prandoni; S Luni; P Zerbinati; D Sartor; F Franz; A Girolami
Journal:  Haematologica       Date:  2001-12       Impact factor: 9.941

3.  A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.

Authors:  S Middeldorp; J R Meinardi; M M Koopman; E C van Pampus; K Hamulyák; J van Der Meer; M H Prins; H R Büller
Journal:  Ann Intern Med       Date:  2001-09-04       Impact factor: 25.391

4.  Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.

Authors:  A Gerhardt; R E Scharf; M W Beckmann; S Struve; H G Bender; M Pillny; W Sandmann; R B Zotz
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

5.  Trends and racial differences in birth weight and related survival.

Authors:  G R Alexander; M E Tompkins; M C Allen; T C Hulsey
Journal:  Matern Child Health J       Date:  1999-06

6.  Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.

Authors:  B M Sibai; S Caritis; J Hauth; M Lindheimer; J P VanDorsten; C MacPherson; M Klebanoff; M Landon; M Miodovnik; R Paul; P Meis; M Dombrowski; G Thurnau; J Roberts; D McNellis
Journal:  Am J Obstet Gynecol       Date:  2000-02       Impact factor: 8.661

7.  Pregnancy-related mortality in the United States, 1991-1997.

Authors:  Cynthia J Berg; Jeani Chang; William M Callaghan; Sara J Whitehead
Journal:  Obstet Gynecol       Date:  2003-02       Impact factor: 7.661

8.  Mutation in blood coagulation factor V associated with resistance to activated protein C.

Authors:  R M Bertina; B P Koeleman; T Koster; F R Rosendaal; R J Dirven; H de Ronde; P A van der Velden; P H Reitsma
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

9.  Absence of association of thrombophilia polymorphisms with intrauterine growth restriction.

Authors:  Claire Infante-Rivard; Georges-Etienne Rivard; Wagner V Yotov; Emmanuelle Génin; Marguerite Guiguet; Clarice Weinberg; Robert Gauthier; Juan Carlos Feoli-Fonseca
Journal:  N Engl J Med       Date:  2002-07-04       Impact factor: 91.245

10.  Cost-effectiveness of screening for the factor V Leiden mutation in pregnant women.

Authors:  Peter Clark; Sara Twaddle; Isobel D Walker; Linda Scott; Ian A Greer
Journal:  Lancet       Date:  2002-06-01       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.